Ranbaxy recalls acne drug

New Delhi, Nov. 20: Ranbaxy Laboratories has recalled from the US market a batch of 4,348 cartons of Sotret Isotretinoin capsules used in treating skin infections.

According to the information available on the US health regulator Food and Drug Admini-stration’s (FDA) website, Ranbaxy through its US-based subsidiary Ranbaxy Laboratories Inc, has issued a ‘nation-wide class III recall’ for a batch of Sotret Isotretinoin capsules of 40 mg strength.